Mark Evans

Mark Evans is an experienced professional in the medical device industry with a focus on regulatory compliance and product development. Currently serving as a DHF Consultant at Maquet-Getting Group since August 2016, Mark Evans has played a key role in developing strategies to address FDA Consent Decree issues for various medical devices, ensuring both remediation and preventive measures are effectively implemented. In addition, Mark Evans has served as Development Manager at GlySure Ltd since October 2012, and has held various management and development roles at companies including AbD Serotec, Olympus, Beckman Coulter Biomedical, Quest Diagnostics, and Kalibrant. Mark Evans possesses a proven track record in product development and regulatory submissions, particularly in the context of critical medical devices.